Reasons for inadequate utilization of cognitive-behavioral therapy for obsessive-compulsive disorder.
Open accessAbstract
Article AbstractBecause this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Cognitive-behavioral therapy (CBT) has repeatedly beenfound to be effective in the treatment of obsessive-compulsivedisorder (OCD),1 and the Expert Consensus Guidelines for theTreatment of OCD2 recommend CBT as a first-line treatmentof adult OCD along with serotonin reuptake-inhibiting drugs.However, many OCD sufferers never receive adequate CBTtreatment; for example, Mancebo et al.3 recently found that only38% of OCD sufferers taking part in a longitudinal study ofOCD at a major medical center had undergone an adequate trialof CBT in their lifetime. We undertook an Internet-based surveystudy to better understand this phenomenon in the larger OCDpopulation.†‹
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Barriers to treatment seeking in OCD include direct and indirect costs of treatment, limited number of mental health professionals skilled in treating anxiety disorders, and stigma.
“Barriers to treatment seeking in this population are similar to those relevant to other anxiety disorders, and include the direct and indirect costs of treatment, the limited number of mental health professionals skilled in the treatment of anxiety disorders, and stigma [8], [9], [10].”
From The acceptability of internet-based treatment and characteristics of an adult sample with obsessive compulsive disorder: An internet survey (2011) · cites this paper as [8]
The Results (page not available in our copy) report that some respondents did not seek CBT for OCD because they could not afford it (15%) or had no specialist nearby (25%). The paper does not address indirect costs or stigma, and its findings concern CBT specialists for OCD rather than professionals treating anxiety disorders generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · see citing works
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978 · see citing works
Howard, W. J. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70316-0 · Cited by 905 · see citing works
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/g1ga-9884 · Cited by 748 · see citing works
Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470 · see citing works
de Abajo, F. J., Rodríguez, L. A. G., & Montero, D. (1999) · BMJ · doi:10.1136/bmj.319.7217.1106 · Cited by 454 · see citing works
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
Fagiolini, A. M., Frank, E., Scott, J., Turkin, S. R., & Kupfer, D. J. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00234.x · Cited by 451 · see citing works
Fisher, P. L., & Wells, A. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.007 · Cited by 377 · see citing works
Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., & Farfel, G. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0508 · Cited by 243 · see citing works
Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218 · see citing works
Fluoxetine Versus Placebo in Posttraumatic Stress Disorder
Martényi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0305 · Cited by 215 · see citing works
Antiepileptic Drug Hypersensitivity Syndrome
Schlienger, R. G., & Shear, N. H. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01678.x · Cited by 171 · see citing works
Mechanisms of Idiosyncratic Hypersensitivity Reactions to Antiepileptic Drugs
Leeder, J. S. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01679.x · Cited by 158 · see citing works
Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., Nutt, D., Marshall, R. D., Nemeroff, C. B., Shalev, A. Y., & Yehuda, R. (2004) · PubMed · Cited by 146 · see citing works
Hematologic Side Effects of Psychotropics
Oyesanmi, O., Kunkel, E. J. S., Monti, D., & Field, H. L. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71206-5 · Cited by 117 · see citing works
Retinopathy associated with high-dose interferon alfa-2b therapy
Hejny, C., Sternberg, P., Lawson, D. H., Greiner, K., & Aaberg, T. M. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00836-4 · Cited by 108 · see citing works
A Systematic Review of Placebo Response in Studies of Bipolar Mania
Sysko, R., & Walsh, B. T. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0807 · Cited by 76 · see citing works
Oxcarbazepine Treatment of Bipolar Disorder
Ghaemi, S. N., Berv, D. A., Klugman, J., Rosenquist, K. J., & Hsu, D. J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0813 · Cited by 70 · see citing works
Oxcarbazepine in the Treatment of Bipolar Disorder: A Review
Pratoomsri, W., Yatham, L. N., Bond, D. J., Lam, R. W. M., & Sohn, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100809 · Cited by 41 · see citing works
Oxcarbazepine in the treatment of bipolar and schizoaffective disorders
Popova, E., Leighton, C., Bernabarre, A., Bernardo, M., & Vieta, E. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.617 · Cited by 34 · see citing works
Psychiatry: from interest in conflicts to conflicts of interest.
Vieta, E. (2007) · PubMed · Cited by 32 · see citing works
Oxcarbazepine in bipolar disorder: a critical review of the literature
Mazza, M., Nicola, M. D., Martinotti, G., Taranto, C., Pozzi, G., Conte, G., Janiri, L., Bria, P., & Mazza, S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.5.649 · Cited by 27 · see citing works
Safety of the Treatment of Interferon-Alpha-Induced Depression
Loftis, J. M., & Hauser, P. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.6.524 · Cited by 27 · see citing works
Pancytopenia Associated With the Introduction of Oxcarbazepine
Calamaras, M. R., Stowe, Z. N., & Newport, D. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264971.92828.b2 · Cited by 26 · see citing works
Oxcarbazepine-Induced Thrombocytopenia
Mahmud, J., Mathews, M., Verma, S., & Basil, B. (2005) · Psychosomatics · doi:10.1176/appi.psy.47.1.73 · Cited by 26 · see citing works
Oxcarbazepine add‐on in the treatment of refractory bipolar disorder
Pratoomsri, W., Yatham, L. N., Sohn, C., Solomons, K., & Lam, R. W. M. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00253.x · Cited by 26 · see citing works
Yamamoto, K., Honda, T., Matsushita, T., Kojima, T., & Takamatsu, J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01761.x · Cited by 19 · see citing works
Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD
Davidson, J. R. T., Landerman, L. R., & Clary, C. M. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.005 · Cited by 19 · see citing works
Ribavirin and Use of Clotting Factors in Patients With Hemophilia and Chronic Hepatitis C
Honda, T., Toyoda, H., Hayashi, K., Katano, Y., Yano, M., Nakano, I., Yoshioka, K., Goto, H., Yamamoto, K., & Takamatsu, J. (2005) · JAMA · doi:10.1001/jama.293.10.1190-c · Cited by 12 · see citing works
Ballenger, J. C. (2009) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)79085-6 · Cited by 8 · see citing works
Flagged first, then by citations
Research works printed but not linked: 15
- Mancebo MC, Eisen JL, Pinto A, et al. The Brown Longitudinal Ob- sessive Compulsive Study: treatments received and patient impres- sions of improvement. J Clin Psychiatry 2006;67:1713-1720
- Rockville, Md: National Institute of Mental Health; 1976:218-222 REFERENCES
- Rockville, Md: National Institute of Mental Health; 1976:218-222
- Global Assessment of Functioning (GAF) Scale. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:32
- Weinrieb RM, Auriacombe M, Lynch KG, et al. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. PSYCHIATRIST.COM J Clin Psychiatry 2003;64:1502-1510
- McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-1492
- Morasco BJ, Rifai MA, Loftis JM, et al. A randomized trial of parox- etine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord 2007;103:83-90 REFERENCES
- Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000 Apr;283(14):1837-1844
- Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double- blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 2007 May;68(5):711-720
- Goldsmith DR, Wagstaff AJ, Ibbotson T, et al. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003;63(19):2029-2050
- Khanna S, Vieta E, Lyons B, et al. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005;187:229-234
- Hirschfeld RM, Keck PE Jr, Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week, multicentre, double-blind, placebo-controlled trial. Am J Psychiatry 2004;161(6):1057-1065
- Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48(1):62-68
- Zhang ZJ, Kang WH, Tan QR, et al. Adjunctive herbal medicine with REFERENCES 1. Sysko R, Walsh BT. A systematic review of placebo response in stud- ies of bipolar mania. J Clin Psychiatry 2007;68(8):1213-1217
- Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287:1840-1847
Cited by
Sorted by citations
Remote cognitive-behavior therapy for obsessive-compulsive symptoms: A meta-analysis.
Wootton, B. M. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.10.001 · Cited by 162 · see citing works
Remote treatment of obsessive-compulsive disorder: A randomized controlled trial
Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2013.07.002 · Cited by 125 · see citing works
Wootton, B. M., Titov, N., Dear, B. F., Spence, J., & Kemp, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020548 · Cited by 116 · see citing works
An Internet administered treatment program for obsessive–compulsive disorder: A feasibility study
Wootton, B. M., Titov, N., Dear, B. F., Spence, J., Andrews, G., Johnston, L., & Solley, K. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.07.009 · Cited by 72 · see citing works
THE PUBLIC'S KNOWLEDGE AND BELIEFS ABOUT OBSESSIVE COMPULSIVE DISORDER
Coles, M. E., Heimberg, R. G., & Weiss, B. D. (2013) · Depression and Anxiety · doi:10.1002/da.22080 · Cited by 54 · see citing works
“[22, 25] In addition, lacking knowledge of how to access treatment and underestimating the potential benefits of treatment predict failure to seek treatment.[16, 25] The ability to recognize psychiatric symptoms and the associated beliefs regarding the likely course and consequences of the symptoms are collectively re…”
BackgroundWootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2014) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2014.03.001 · Cited by 38 · see citing works
Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2015) · Internet Interventions · doi:10.1016/j.invent.2015.05.003 · Cited by 34 · see citing works
“However, there are numerous barriers to accessing traditional face-to-face treatments, including the direct and indirect costs of treatment, stigma, and difficulty accessing a trained therapist (Baer and Minichiello, 2008; Belloch et al., 2009; Goodwin et al., 2002; Marques et al., 2010).”
BackgroundLind, C., Boschen, M. J., & Morrissey, S. (2013) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.09.004 · Cited by 33 · see citing works
Efficacy of intensive CBT telehealth for obsessive-compulsive disorder during the COVID-19 pandemic
Pinciotti, C. M., Bulkes, N. Z., Horvath, G., & Riemann, B. C. (2021) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2021.100705 · Cited by 31 · see citing works
Fisher, P., Cherry, M., Stuart, T., Rigby, J., & Temple, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.019 · Cited by 20 · see citing works
Gellatly, J. L., Pedley, R., Molloy, C., Butler, J. A., Lovell, K., & Bee, P. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1238-x · Cited by 22 · see citing works
Zhang, W., Yang, W., Ruan, H., Gao, J. P., & Wang, Z. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.10.025 · Cited by 21 · see citing works
Pozza, A., Andersson, G., Antonelli, P., & Dèttore, D. (2014) · Cognitive Behaviour Therapy · doi:10.1017/s1754470x1400021x · Cited by 20 · see citing works
“Consequently, people who seek help for OCD often face the problem of long waiting lists for trained psychotherapists, which causes many OCD sufferers to remain untreated or inadequately treated (Baer & Minichiello, 2008).”
BackgroundFranklin, M. E., Engelmann, J. M., Bulkes, N. Z., Horvath, G., Piacsek, K., Osterlund, E., Freeman, J. B., Schwartz, R. A., Himle, M. B., & Riemann, B. C. (2023) · JAACAP Open · doi:10.1016/j.jaacop.2023.09.007 · Cited by 15 · see citing works
Wang, Y., Amarnath, A., Miguel, C., Čihařová, M., Lin, J., Zhao, R., Struijs, S. Y., de Wit, L. M., Toffolo, M. B. J., & Cuijpers, P. J. (2024) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2024.152453 · Cited by 11 · see citing works
Lisi, D. M., Hawley, L. L., McCabe, R., Rowa, K., Cameron, D., Richter, M. A., & Rector, N. (2023) · Clinical Psychology and Psychotherapy · doi:10.1002/cpp.2908 · Cited by 8 · see citing works
Distance Treatment of Obsessive–Compulsive Disorder
Wootton, B., & Titov, N. (2010) · Behaviour change · doi:10.1375/bech.27.2.112 · Cited by 12 · see citing works
“Despite the prevalence of OCD, it is a disorder that often goes untreated, or treatment is delayed for many years (Abramowitz, 1996; Baer & Minichiello, 2008; Crino et al., 2005).”
BackgroundWaks, S., Moses, K., & Wootton, B. M. (2024) · British Journal of Clinical Psychology · doi:10.1111/bjc.12462 · Cited by 9 · see citing works
The experiences of help-seeking in people with obsessive compulsive disorder: an internet survey
Vuong, T. M., Gellatly, J. L., Lovell, K., & Bee, P. (2016) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x1600009x · Cited by 10 · see citing works
“…include worries about medical insurance and cost of treatment (Baer & Minichiello, 2008; Marques et al. 2010), fear of stigma and shame (Marques et al. 2010; Belloch et al. 2009), and views about treatment ineffectiveness (Baer & Minichiello, 2008; Marques et al. 2010; Goodwin et al. 2002).”
BackgroundWang, Y., Miguel, C., Čihařová, M., Amarnath, A., Lin, J., Zhao, R., Toffolo, M. B. J., Harrer, M., Struijs, S. Y., de Wit, L. M., et al. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.197 · Cited by 7 · see citing works
Rezaee, R., Parsa, Z., Ahmadzadeh, L., Ahmadian, L., Avazzadeh, S., & Marzaleh, M. A. (2023) · Health Science Reports · doi:10.1002/hsr2.1577 · Cited by 4 · see citing works
Pozza, A., Andersson, G., & Dèttore, D. (2015) · Psychology Research and Behavior Management · doi:10.2147/prbm.s83872 · Cited by 4 · see citing works
Internet-Delivered Cognitive Behavior Therapy (ICBT) for Obsessive-Compulsive Disorder
Wootton, B. M., Andersson, E., & Rück, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-06083-5_6 · Cited by 3 · see citing works
Matsumoto, K., Hamatani, S., Shimizu, E., Yoshino, K., Shirayama, Y., & Sato, K. (2020) · Anxiety Disorder Research · doi:10.14389/jsad.12.1_45 · Cited by 2 · see citing works
Technological Interventions for Obsessive–Compulsive Disorder Management
Borgnis, F., & Pedroli, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00096-0 · Cited by 2 · see citing works
- Authors
- Baer, L., & Minichiello, W. E.
- Affiliations
- Harvard University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-04-15
- Volume
- 69
- Issue
- 4
- Pages
- 676
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2023712936
- Cited by
- 28
- References
- 31
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Servier
- H. Lundbeck A/S
- Cilag
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- obsessive-compulsive disorder, cognitive behavioral therapy, treatment utilization, barriers to treatment, internet-based survey, guideline adherence
- MeSH terms
- Attitude to Health, Data Collection, Humans, Obsessive-Compulsive Disorder, Cognitive Behavioral Therapy, Treatment Refusal, Internet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
